To validate the synergistic effect of IL-21 and PD-L1 on Treg generation in the tumor microenvironment, we used tumor explants freshly isolated from cancer patients to induce Treg generation from CD4+ T cells and to test whether neutralizing IL-21 and PD-1 was capable of blocking Treg generation. Here, IL21 is linked to neoplasm.